Background Previous studies suggest a possible association between maternal use of
selective serotonin-reuptake inhibitors (SSRIs) during early pregnancy and congenital heart …

Objectives To investigate the proposed synergistic teratogenic effect of use of selective
serotonin receptor inhibitors (SSRI) together with sedatives or hypnotics, primarily …

Objective To study the association between parental depression and maternal
antidepressant use during pregnancy with autism spectrum disorders in offspring. Design …

Pharmacotherapy in pregnant women is often necessary to treat chronic or relapsing
depression or anxiety disorders. Studies that have evaluated the safety of selective …

Background: The reproductive safety of selective reuptake inhibitor (SRI) antidepressants
needs to be established to provide optimal control of maternal depression while protecting …

Gentile S. Selective serotonin reuptake inhibitor exposure during early pregnancy and the
risk of birth defects. Objective: To assess the methodological value of studies that signaled …

Objective To examine the risk of ASD in children associated with antidepressant use during
pregnancy according to trimester of exposure and taking into account maternal depression …

Objective To investigate whether in utero exposure to antidepressants is associated with
increased risk of attention deficit hyperactivity disorder (ADHD). Design Cohort study. Setting …

Maternal depression in pregnancy is common, and selective serotonin reuptake inhibitors
(SSRIs) are the most frequently prescribed antidepressant medications used for its …

Abstract Purpose of Review To provide an updated summary and appraisal of work from
2019 to 2022 examining risks of selective serotonin reuptake inhibitor (SSRI) use in …